Knowra Pramipexole Pramipexole Pramipexole is an orally active dopamine agonist that stimulates dopamine receptors, especially D2-like receptors. It is used to treat Parkinson’s disease and restless legs syndrome.
Dopamine receptor : A cell-surface receptor that responds to dopamine and helps regulate movement, motivation, and other functions. Pramipexole activates this receptor family without requiring dopamine release.
Parkinson's disease : A progressive neurodegenerative disorder marked by motor symptoms caused largely by loss of dopamine-producing neurons. Pramipexole can relieve motor symptoms, alone early or with levodopa later.
Ropinirole : An orally administered dopamine agonist used to treat Parkinson’s disease and restless legs syndrome. It shares pramipexole’s main indications but has a different chemical structure and metabolism.
Orthostatic hypotension : A sustained fall in blood pressure after standing, which can cause dizziness or fainting. Pramipexole may worsen postural blood-pressure drops, especially during dose increases.
D3 receptor : A dopamine receptor subtype concentrated in limbic brain regions and also found in motor circuits. Pramipexole has especially high affinity for this D2-like subtype.
Restless legs syndrome : A neurological disorder causing an urge to move the legs, usually with unpleasant sensations at rest and at night. Pramipexole reduces symptoms, though long-term use can worsen them through augmentation.
Rotigotine : A dopamine agonist delivered through a transdermal patch for Parkinson’s disease and restless legs syndrome. Its continuous skin delivery contrasts with pramipexole’s oral dosing.
Hallucination : A perception occurring without an external stimulus, such as seeing or hearing something absent. Hallucinations can occur with pramipexole, particularly in older people with Parkinson’s disease.
Dopamine : A neurotransmitter involved in movement, motivation, reward, and hormonal regulation. Pramipexole mimics dopamine’s action when signaling is deficient.
Levodopa : A dopamine precursor converted into dopamine in the brain and used to treat Parkinson’s disease. Unlike levodopa, pramipexole directly stimulates dopamine receptors.
Show all 21